We are thrilled to announce that EurekaBio has received silver certification in the EcoVadis social responsibility rating for 2024, placing us in the top 15% among all evaluated companies and the top 5% in our industry. This recognition reflects our outstanding performance in corporate social responsibility and sustainable development practices.

EcoVadis is a renowned global provider of corporate social responsibility ratings, having served over 130,000 companies worldwide. They have recognized our excellent performance in integrating our CSR and sustainable development principles into our business and management operations. The accessment process, based on international CSR standards, evaluates performance across 21 indicators spanning four main themes: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement.

At EurekaBio, we have excelled in all four of these areas. We believe that effectively managing corporate social responsibility and sustainable development practices is crucial for both our organization and society as a whole. Our commitment lies in supporting the development of accessible and innovative therapies to reach more patients and address unmet medical needs. Continuous improvement is a cornerstone of our culture. We are dedicated to creating lasting value for society, the environment, and our company. By fostering essential innovations in biotechnology, we strive to advance the frontiers of treatment and contribute positively to the world.